# Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Regorafenib Monotherapy

> **NCT03010722** · — · COMPLETED · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 49 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Regorafenib

## Key facts

- **NCT ID:** NCT03010722
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2017-01
- **Final completion:** 2017-07
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2021-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03010722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03010722, "Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Regorafenib Monotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03010722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*